Log in or Sign up for Free to view tailored content for your specialty!
Scleroderma News
‘Aggressive’ treatment of GERD improves survival in systemic sclerosis with ILD
“Aggressive” combination therapy for gastroesophageal reflux disease improved survival among patients with systemic sclerosis and interstitial lung disease, according to data published in Arthritis Research & Therapy.
Collaborative systemic sclerosis care comes with challenges, but improves outcomes
ORLANDO, Fla. — Including multiple specialists to treat the various facets of systemic sclerosis improves outcomes but can have its own challenges, according to a presenter at the 2024 Rheumatology Nurses Society annual conference.
Log in or Sign up for Free to view tailored content for your specialty!
CAR T cells one year later: What have we learned?
Nearly 1 year ago, I wrote my first editorial about the emergence and excitement surrounding the early experience with CAR T cells — CAR T Cells in Autoimmunity: A Potential Therapy About to Explode.
CAR T-cell therapy may be a ‘miracle,’ but it is too soon to say ‘cure’
It has been at least 2 years since the first cohort of patients with lupus underwent chimeric antigen receptor T-cell treatment, and, at least so far, for every one of them, each new dawn represents another day spent in full remission.
Internal organ involvement ‘much more’ common in late-onset systemic sclerosis
Internal organ, heart and kidney involvement, as well as pulmonary arterial hypertension, are “much more” common in cases of systemic sclerosis that develop after age 60 years, according to data published in Clinical Rheumatology.
US Supreme Court decision on mifepristone ‘not a victory, but a punt’
On June 13, the U.S. Supreme Court rejected a lawsuit that challenged the FDA’s approach to regulating the abortion pill mifepristone.
Men with systemic sclerosis who smoke face greater excess mortality than women
Men with systemic sclerosis who smoke demonstrate a greater risk for death than women with SSc who smoke, according to a study published in RMD Open.
Racing modified cells against each other in humans may be the next step in gene therapies
The next evolution of gene therapies may involve pitting T cells with different modifications against one another in a “race” inside a human to determine which edits produce the best results against a tumor, an expert panel predicted.
‘Be aggressive’ in detecting, managing interstitial lung disease in early scleroderma
DESTIN, Fla. — Detection and treatment of interstitial lung disease in systemic sclerosis calls for early and aggressive action, according to data presented at the Congress of Clinical Rheumatology East.
'Quelling anxiety' essential for rheumatologists ensuring safe pregnancies
DESTIN, Fla. — Ongoing, frank discussions about reproductive health with patients of childbearing age is critical to safe pregnancy outcomes, according to a presenter at the Congress of Clinical Rheumatology East.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read